Cargando…

Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials

In heart failure (HF) patients, remote monitoring using implantable devices may be used to predict and reduce HF exacerbations and mortality. Data from randomized controlled trials (RCTs) was assessed to determine the effectiveness of implantable remote monitoring on the improvement of outcomes in H...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajduczok, Alexander G., Muallem, Samer N., Nudy, Matthew S., DeWaters, Ami L., Boehmer, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460850/
https://www.ncbi.nlm.nih.gov/pubmed/34559368
http://dx.doi.org/10.1007/s10741-021-10150-5
_version_ 1784571847429324800
author Hajduczok, Alexander G.
Muallem, Samer N.
Nudy, Matthew S.
DeWaters, Ami L.
Boehmer, John P.
author_facet Hajduczok, Alexander G.
Muallem, Samer N.
Nudy, Matthew S.
DeWaters, Ami L.
Boehmer, John P.
author_sort Hajduczok, Alexander G.
collection PubMed
description In heart failure (HF) patients, remote monitoring using implantable devices may be used to predict and reduce HF exacerbations and mortality. Data from randomized controlled trials (RCTs) was assessed to determine the effectiveness of implantable remote monitoring on the improvement of outcomes in HF patients. A systematic review and meta-analysis of RCTs testing remote monitoring versus standard of care for management of HF patients was performed. Primary endpoints were all-cause mortality and a composite of cardiovascular (CV) and HF hospitalizations. Rate ratios (RRs) and 95% confidence intervals (CI) were calculated. A secondary analysis tested for heterogeneity of treatment effect (HTE) comparing right ventricular/pulmonary pressure monitoring versus impedance-based monitoring on hospitalization. A regression analysis was performed using the mean follow-up time as the moderator on each primary endpoint. Eleven RCTs (n = 6196) were identified with a mean follow-up of 21.9 months. The mean age and reported ejection fraction were 64.1 years and 27.7%, respectively. Remote monitoring did not reduce mortality (RR 0.89 [95% CI 0.77, 1.03]) or the composite of CV and HF hospitalizations (RR 0.98 [0.81, 1.19]). Subgroup analysis found significant HTE for hospitalizations between those studies that used right ventricular/pulmonary pressure monitoring versus impedance-based monitoring (I(2) = 87.1%, chi(2) = 7.75, p = 0.005). Regression analysis found no relationship between the log rate ratio of remote monitoring’s effect on mortality, CV hospitalization or HF hospitalization, and mean follow-up time. Compared to standard of care, remote monitoring using implantable devices did not reduce mortality, CV, or HF hospitalizations. However, right ventricular/pulmonary pressure monitoring may reduce HF hospitalizations, which will need to be explored in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-021-10150-5.
format Online
Article
Text
id pubmed-8460850
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-84608502021-09-24 Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials Hajduczok, Alexander G. Muallem, Samer N. Nudy, Matthew S. DeWaters, Ami L. Boehmer, John P. Heart Fail Rev Article In heart failure (HF) patients, remote monitoring using implantable devices may be used to predict and reduce HF exacerbations and mortality. Data from randomized controlled trials (RCTs) was assessed to determine the effectiveness of implantable remote monitoring on the improvement of outcomes in HF patients. A systematic review and meta-analysis of RCTs testing remote monitoring versus standard of care for management of HF patients was performed. Primary endpoints were all-cause mortality and a composite of cardiovascular (CV) and HF hospitalizations. Rate ratios (RRs) and 95% confidence intervals (CI) were calculated. A secondary analysis tested for heterogeneity of treatment effect (HTE) comparing right ventricular/pulmonary pressure monitoring versus impedance-based monitoring on hospitalization. A regression analysis was performed using the mean follow-up time as the moderator on each primary endpoint. Eleven RCTs (n = 6196) were identified with a mean follow-up of 21.9 months. The mean age and reported ejection fraction were 64.1 years and 27.7%, respectively. Remote monitoring did not reduce mortality (RR 0.89 [95% CI 0.77, 1.03]) or the composite of CV and HF hospitalizations (RR 0.98 [0.81, 1.19]). Subgroup analysis found significant HTE for hospitalizations between those studies that used right ventricular/pulmonary pressure monitoring versus impedance-based monitoring (I(2) = 87.1%, chi(2) = 7.75, p = 0.005). Regression analysis found no relationship between the log rate ratio of remote monitoring’s effect on mortality, CV hospitalization or HF hospitalization, and mean follow-up time. Compared to standard of care, remote monitoring using implantable devices did not reduce mortality, CV, or HF hospitalizations. However, right ventricular/pulmonary pressure monitoring may reduce HF hospitalizations, which will need to be explored in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-021-10150-5. Springer US 2021-09-24 2022 /pmc/articles/PMC8460850/ /pubmed/34559368 http://dx.doi.org/10.1007/s10741-021-10150-5 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Hajduczok, Alexander G.
Muallem, Samer N.
Nudy, Matthew S.
DeWaters, Ami L.
Boehmer, John P.
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title_full Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title_fullStr Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title_full_unstemmed Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title_short Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
title_sort remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460850/
https://www.ncbi.nlm.nih.gov/pubmed/34559368
http://dx.doi.org/10.1007/s10741-021-10150-5
work_keys_str_mv AT hajduczokalexanderg remotemonitoringforheartfailureusingimplantabledevicesasystematicreviewmetaanalysisandmetaregressionofrandomizedcontrolledtrials
AT muallemsamern remotemonitoringforheartfailureusingimplantabledevicesasystematicreviewmetaanalysisandmetaregressionofrandomizedcontrolledtrials
AT nudymatthews remotemonitoringforheartfailureusingimplantabledevicesasystematicreviewmetaanalysisandmetaregressionofrandomizedcontrolledtrials
AT dewatersamil remotemonitoringforheartfailureusingimplantabledevicesasystematicreviewmetaanalysisandmetaregressionofrandomizedcontrolledtrials
AT boehmerjohnp remotemonitoringforheartfailureusingimplantabledevicesasystematicreviewmetaanalysisandmetaregressionofrandomizedcontrolledtrials